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Abstract: Objectives: The Philadelphia Lead Safe Homes (LSH) Study was designed to 
evaluate whether educational and environmental interventions in the first year of life for 
families of newborns increased knowledge of lead exposure prevention and were 
associated with less elevation of blood lead levels (BLLs) for these children, when 
compared to children receiving standard care. Methods: The current study performed 
descriptive statistics on the second-year BLL data for both groups and compared these 
using chi-square tests for proportions and unpaired t-tests for means. Results: A BLL result 
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was found for 159 (50.6%) of the 314 LSH cohort children and 331 (52.7%) of the 628 
control children (p = 0.1). Mean and standard deviation for age at draw was 23.8 (3.4) 
months versus 23.6 (3.1) months (P = 0.6). Geometric mean BLLs were 3.7 versus 3.5 µg/dL 
(P = 0.4). The percentages of the cohort group with a BLL of ≥20, ≥10 and ≥5 μg/dL, 
respectively, were 0.6%, 5% and 30%; for the controls 1.2%, 6.6%, and 25%. These 
percentages were not significantly different between groups. Conclusion: A comparison of 
geometric mean BLLs and percentages above several BLL cut points drawn at age two 
years in a group of urban newborns benefitting from study interventions versus a group of 
similar urban children did not yield statistically significant differences. Both groups had 
relatively lower lead levels when compared to historical cohort groups, which may reflect a 
continuing downward trend in BLLs in U.S. children. The interventions did result in 
benefits to the families such as an increase in parental knowledge about lead exposure 
prevention and in-home wet cleaning activity, and a decrease in lead dust levels in study 
homes.  
Keywords: childhood lead poisoning; primary prevention of lead exposure; blood lead 
levels; children’s environmental health 
 
1. Introduction 
Primary prevention of lead exposure and lead poisoning in U.S. children has been recommended by 
the Centers for Disease Control and Prevention in several recent publications [1,2]. Prevention of lead 
exposure and elevated blood lead levels (BLLs) (level ≥10 micrograms per deciliter—µg/dL) has been 
increasingly endorsed due to the large number of studies documenting the adverse effects. These 
effects include various types of neuropsychological impairment impacting intelligence or IQ, academic 
performance, attention, development, and behavior; some studies suggest adverse effects at blood lead 
levels less than 10 µg/dL [2–9]. Lead has also been associated with many other adverse effects that 
include juvenile delinquency, anemia, effects on growth and the endocrine system, dental caries, and 
rarely, encephalopathy with or without death [2,4,5]. The main sources for exposure for U.S. children 
remain home-based lead hazards generated by deterioration of lead-based paint in pre-1978 housing 
and exposure to various products containing lead such as toys, consumer products, home remedies, 
foods and cosmetics [10,11]. Primary prevention involves prospectively preventing exposure to lead, 
such as preventing or remediating lead hazards in housing before any resident children are exposed and 
poisoned. One of the few studies of household-level primary prevention done previously was a 
randomized controlled trial of lead dust control in 275 urban children [12]. The effectiveness of dust 
control measures in preventing or limiting elevation of BLLs was then assessed. The intervention 
group received cleaning equipment, supplies and multiple (up to 8) visits with a lead dust control 
advisor versus no intervention for the control group. The authors found no differences in BLL or dust 
levels between groups. The baseline (6-month) geometric mean (GM) BLLs and 95% confidence 
intervals were 2.8 (2.5, 3.1) µg/dL in the intervention group versus 2.9 (2.7, 3.2) µg/dL in the control 
group and rose steadily in both groups. Levels at 12 months were 5.5 (4.9, 6.2) µg/dL and 5.9 (5.3, 6.6) µg/dL Int. J. Environ. Res. Public Health 2012, 9 1218 
 
 
and peak BLLs at age 24 months were 7.3 (6.6, 8.2) µg/dL and 7.8 (6.9, 8.7) µg/dL, respectively. At 
24 months 39 (31%) and 43 (36%) of intervention and control children had BLLs ≥10 µg/dL (p = 0.4), 
and 6 (5%) and 8 (7%) had BLLs ≥20 µg/dL (p = 0.5). A follow-up study at 48 months also found no 
difference in BLLs although GMs and 95% confidence intervals had decreased to 5.9 (5.3, 6.7) and 6.1 
(5.5, 6.9) µg/dL, respectively [13].
 A randomized control trial by Jordan et al. of 299 intervention 
subjects in Minneapolis, Minnesota aged 0-36 months who received 20 bi-weekly educational sessions 
on how to prevent lead exposure over one year with quarterly follow-up sessions for another 2 years 
compared them to 308 control children whose families only received lead poisoning prevention 
brochures [14]. BLLs were obtained every 4 months; for the 378 children with sufficient BLL data 
23% developed BLLs >10 µg/dL before age 3 years; 81% of intervention subjects versus 73%   
(p = 0.08) of control subjects maintained BLLs under 10 µg/dL; and the intervention reduced the risk of a 
BLL ≥10 µg/dL by 34%. Mean BLLs were not reported [14]. Other previous studies were reviewed in our 
earlier paper and found little evidence that educational or other simple household-level interventions would 
reduce BLLs [15]. 
The Philadelphia Lead Safe Homes Study evaluated whether educational and environmental 
interventions implemented with families of newborns in the first year of life increased knowledge of 
lead exposure prevention and were associated with less elevation of blood lead levels (BLLs) for these 
children, when compared to children and their families receiving standard care without these 
preventive interventions. A recent publication detailed the findings of the Lead Safe Homes study to 
include research findings through the first year of life [15]. This publication gives updated findings 
regarding blood lead level analysis for levels drawn around two years of age. As the first year BLLs 
were drawn at the end of or soon after completion of the study interventions, the second year BLLs 
were of interest in assessing whether the educational and environmental interventions might have had a 
protective effect in leading to lower second year levels, even in the absence of ongoing contact with 
study staff. This was particularly important in determining the degree of intervention that might be 
required for prevention of lead exposure and elevated BLLs.  
2. Experimental Section  
Study methods were detailed previously [15], and will be briefly summarized here. The study had 
two separate arms. One arm was the Lead Safe Homes study, a one-year randomized controlled trial 
for which families of newborns attending urban pediatric practices in Philadelphia were recruited to 
participate. Study interventions for all families in the LSH took place during three home visits starting 
at baseline soon after birth with a follow-up visit at 6 and 12 months. Educational materials stressing 
lead exposure prevention information and activities such as wet mopping and wet dusting for dust 
control using cleaning equipment provided were presented in detail at the first visit and reinforced at 
subsequent visits. Families were randomly assigned to receive standard lead education (standard 
education group or SEG) or standard education supplemented by specific home maintenance education 
(maintenance education group or MEG). This additional home maintenance supplemental material was 
the primary difference between the two groups and gave much detail on essential maintenance 
practices to keep a home in a lead safe condition. All homes were given a visual assessment and lead 
dust testing of three surfaces at baseline and 12 months. Most homes had some lead hazards and Int. J. Environ. Res. Public Health 2012, 9 1219 
 
 
parents in either group were offered free lead remediation work conducted by a certified lead 
abatement contractor. Parental reports of blood lead level results were collected in the course of the 
study visits and supplemented by BLL data from both the subjects’ health care providers and the 
Childhood Lead Poisoning Prevention Program of the Philadelphia Department of Public Health 
(PDPH). Other data, including environmental and demographic data, were collected during the three 
study visits; these included 310 and 110 families for first and third visits, as considerable attrition of 
subjects occurred during the study.  
The other arm of the study was a comparison group for the LSH Study as a whole. Since all LSH 
families received substantial education and follow-up, it was of interest to compare them, as a whole, 
to a group of comparable children not given any study-specific interventions. A de-identified dataset of 
BLLs and ages within the electronic database of The Children’s Hospital of Philadelphia for children 
seen for primary care services was provided by the Pediatric Research Consortium for The Children’s 
Hospital of Philadelphia practices. This group served as the comparison group to the intervention 
groups, and was matched 2:1 by age, gender, census tract and racial/ethnic background with LSH 
cohort children. Eight children could not be matched on racial/ethnic background but were matched for 
the other characteristics. The research protocol was approved by the institutional review boards of the 
Philadelphia Department of Public Health, the Children’s Hospital of Philadelphia, the National 
Nursing Centers Consortium, St. Christopher’s Hospital for Children, and Drexel University. 
Key study results published previously from this study [15] included significantly increased 
knowledge in both LSH randomized groups, which was retained over time, and a significant drop in 
lead dust levels for those two groups combined, with 36.9% above the EPA’s standards (250 µg/sq.ft. 
for windowsills and 40 µg/sq.ft. for floors) at baseline compared with 26.9% at 12 months, which was 
mostly due to a decrease in windowsill lead dust levels (p = 0.03). Although 274 (89.5%) and 58 
(57.4%) families were referred for lead hazard remediation work at baseline and at 12 months, only 
twenty-eight percent (78 families) completed the process to achieve this. There were no other obvious 
lead sources identified, such as ceramics, folk remedies, cosmetics, foods, etc.; 4.8% had possible lead 
exposure from hobbies; and 39.8% of parents reported ever working in auto mechanics, battery plants, 
construction or other jobs potentially associated with lead exposure. A quarterly cleaning summary 
looked at wet dusting and wet mopping in key rooms of the home. Over the course of the study both 
the MEG and SEG groups improved their cleaning activity; the only significant difference was a higher 
percent with frequent mopping of dining rooms by SEG (44%), versus MEG (23%) families (p = 0.04). 
There were very few significant differences between the SEG and MEG groups [15].  
A main study hypothesis tested in the current analysis was that interventions would lower the BLLs 
in the LSH study cohort when compared to the matched comparison group of children. In our report at 
one year, a significantly higher percent of LSH cohort children (88.9%; 279 children) had a BLL 
drawn around the first birthday compared to the control group (84.4%; 530 children) (p = 0.03). 
Geometric mean (GM) levels at age one year were 2.6 and 2.7, respectively, for the LSH cohort and 
control groups, and not significantly different (p = 0.5) [15]. The current study performed descriptive 
statistics on the second-year BLL data for both groups and compared proportions using chi-square tests 
and means using unpaired t-tests. To help normalize the blood lead levels, they were converted to 
logarithms (base 10). We intended to have blood lead levels measured at age one and two years but 
these were drawn by health care providers and not by study staff. As there was variability around the Int. J. Environ. Res. Public Health 2012, 9 1220 
 
 
age at which the first and second blood lead levels were drawn, to increase clarity we will use the 
terms “year 1 BLL” to refer to the first BLL obtained and “year 2 BLL” as that drawn between 18 and 
30 months of age. With the sample sizes achieved and an SD (standard deviation) of about 0.26, a 
mean difference of about 0.067 could be detected with 80% power 1-tailed in log (base 10) BLL, 
which corresponds to roughly a 0.5 to 0.6 difference in geometric mean BLLs. Therefore, the study was 
powered to detect fairly small differences in geometric mean levels. 
In order to look for evidence for a difference in BLLs between the LSH cohort and the matched 
comparison group at two time points, we fitted two linear regression models. The first regression 
model aimed to evaluate the effect of the intervention on changes in BLL between birth and two years 
of age in the LSH group versus the control group. The dependent variable was year 2 BLL. In this 
analysis, we controlled for the exact age when the year 2 BLL was drawn (which varied within the 
window of 18–30 months of age) and type of health insurance (a proxy for socio-economic status) (See 
Appendix).  
The second regression model aimed to evaluate whether there was an additional effect of the 
intervention between the first and second BLL assessments. In this model, year 2 BLL was again the 
dependent variable, while year 1 BLL, the age at year 2 blood draw and type of health insurance were 
the predictor variables. This was fitted to a restricted dataset, as follows. In the original paper [15], we 
were flexible with dates and used all first-test results regardless of whether or not they were close to 
one year of age, but for the current comparison we wanted to clearly differentiate year 1 and year 2 
data in order to determine whether changes between the year 1 BLLs and the year 2 BLLs differed 
between the LSH and control groups. Therefore, we restricted the year 1 BLLs to those that satisfied 
both of two conditions. To be used, the measurement must have been taken: (1) sometime during 6 to 
17.9 months of age and (2) at least three months before the year 2 BLL we used (measured between 
ages 18 to 30 months) (See Appendix).  
A simpler comparison was also performed using an unpaired t-test to compare the two groups (LSH 
and comparison) on the mean changes in the log transformed BLLs between one and two years of age. 
The test was done by using an unpaired rather than a paired t-test because the match was a 2:1 match 
and there were many missing values for the year 2 BLLs for both the LSH and control children.  
3. Results  
Table 1 illustrates the results of the new analysis. As shown in the table, there were no differences 
between the LSH and control children on the percentage who obtained a BLL result, the percentage of 
obtained results that were venous samples, or on mean BLL levels.  
In a separate analysis, when the data was limited to the 140 LSH cohort and 287 control children 
with data at both age points, there were no significant differences in geometric mean BLLs at age one 
year of 2.7 and 2.7 (P = 0.99), respectively, or at two years of 3.6 and 3.5 (p = 0.6), respectively.  
Table 1 also shows the ranges of BLLs in the two groups and a breakdown into intervals. Slightly 
more than a quarter of the children in the combined groups had a BLL ≥5 μg/dL. Although many fewer 
were at more clinically significant levels, we did see some children ≥10 μg/dL: 8/159 in the LSH group 
and 22/331 in the controls, slightly above 5% overall. One and four in the two groups, respectively, 
were ≥20 μg/dL, or about 1%. None of these percentages were significantly different between the groups.  Int. J. Environ. Res. Public Health 2012, 9 1221 
 
 
Table 1. Comparison of the Lead Safe Homes Study cohort and control group BLL values 
at the two year time point (from 18 to 30 months). 
Characteristic  LSH Group  Control Group  P-Value 
Maximum N  314  628  
N (%) with recorded BLL value   159 (50.6%)  331(52.7%)  >0.5 
a 
BLL is venous specimen N (%)  151/158 (95.6%)  304/331 (91.8%)  0.1 
a 
Mean age at draw (months) ± SD  23.8 ± 3.4  23.6 ± 3.1  0.6 
b
 
Median age at draw (months)  24.1  24.2   
Age range (months)  18–30  18–30   
Median blood lead (μg/dL) 3.2  3.3   
GM BLL, μg/dL (95% CI)  3.7 (3.4, 4.0)  3.5 (3.3, 3.7)  0.4 b 
Range of BLLs (μg/dL) (0.8–39.4)  (0.7–33.1)   
Percentages at different BLL levels       
≥5 µg/dL  47/159 (29.6%)  82/331 (24.8%)  0.3 a 
≥10 µg/dL  8/159 (5.0%)  22/331 (6.6%)  0.5 a 
≥20 µg/dL  1/159 (0.6%)  4/331 (1.2%)  0.9 c 
BLLs = blood lead levels; CI = confidence interval; GM = geometric mean; LSH = Lead Safe Homes;  
SD = standard deviation; 
a P-values are two-tailed significance for uncorrected chi-square; 
b P-values are two-tailed 
significance for unpaired t test; 
c P-values are two-tailed significance for continuity corrected chi-square. 
In our initial analysis, to maximize sample size, we used all “first” blood lead values available for 
the subjects; most, but not all, of which were within a window around 1 year of age. For the current 
analysis, we used levels within a 6-month window of 2 years (thus 18 to 30 months), using all 
available data within that window, even if it had been included in the analysis for the previous report.  
There was no evidence for a difference between the LSH cohort and the matched controls at time 2, 
regardless of control for other variables in a linear regression. Several different models were described 
above. None of these comparisons or regressions was even close to significance on the study group 
variable (See Appendix). Regression 1 showed that BLL was lower in those children with private 
health insurance, relative to Medicaid insurance. This significance was not seen in regression 2. Since 
the insurance type effect was significant in the model that did not control for year 1 BLL, we tested for 
an interaction between group and insurance type. The effect of insurance type remained significant (p = 0.03), 
but the interaction was not significant (p = 0.64). The geometric mean BLL was 0.94 lower in private 
patients versus Medicaid for the LSH group, and 0.62 lower in private patients versus Medicaid in the 
controls, a very similar pattern. 
A simpler comparison for mean changes between the year 1 and year 2 by groups found this change 
to be 0.12 versus 0.11 (p = 0.6) for the LSH and control groups, respectively. Lastly, for the two-year 
BLL data geometric means for the SEG (3.9) and the MEG (3.5; p = 0.2) were not significantly 
different, nor for the MEG (3.5) when compared to the control group (3.5; p = 0.97).  
4. Discussion 
Our study differed from the historical studies described in that it twice offered home evaluation and 
remediation of lead hazards, in addition to education and provision of cleaning instructions and 
supplies. While there were positive changes such as increased parental knowledge and cleaning Int. J. Environ. Res. Public Health 2012, 9 1222 
 
 
activity and a decrease in elevated dust lead levels in the home seen with a year-long program 
involving educational and environmental interventions to prevent elevation of blood lead levels in 
urban newborn children, there were not significant differences in blood lead levels between the Lead 
Safe Homes cohort group versus a control group of similar urban children.  
We did see evidence for a lower year 2 BLL in the children covered by private insurance versus 
those with Medicaid, but this did not differ significantly by LSH versus control group (non-significant 
group by insurance interaction). One possible explanation for the overall finding is that families of 
children on private insurance may be able to maintain their homes in better condition. 
Our geometric mean BLLs were in the 2 s at 12 months and 3 s at 24 months. What is interesting is 
that the Lanphear study results, described above and published in 1999 and 2000 [12,13] showed 
baselines lead levels in the 2 s at 6 months, in the 5 s at 12 months, in the 7 s at 24 months and in the 5–6 s 
at 48 months. Their 6-month levels compared with our 12 month results and then they demonstrated a 
steady increase to peak at 24 months, and slowly decline by 48 months. By contrast, the levels in our 
groups rose only slightly (in the 2 s to in the 3 s) by 24 months. This most likely reflects trends seen both 
nationally and in Philadelphia [15,16] within the last few decades of an overall decrease in BLLs in children.  
There might have been a sharper contrast between families receiving and not receiving 
interventions in a city whose lead poisoning prevention program is not as strong and active as the one 
in Philadelphia or in a city whose children have higher BLLs. The control families may have received 
lead exposure prevention from other sources that would have biased the blood lead comparison toward 
a null finding. National public health interventions such as banning lead from use in plumbing, from 
gasoline, from canned goods, and from use in residential housing starting in 1978 have all contributed 
to the lowering of BLLs in the U.S., and demolition of old, substandard properties has likely also 
contributed locally. 
Our analysis found that 0.6% and 1.2%, 5% and 6.6%, 30% and 25% of the cohort and control 
groups had a BLL of ≥20,  ≥10 and ≥5  μg/dL, respectively, which was not significantly different 
between groups. These were much lower percentages for ≥20 and ≥10 μg/dL than for the Lanphear and 
Jordan studies, which didn’t even calculate levels ≥5 μg/dL. With increasing concerns about adverse 
effects at BLLs <10 μg/dL there may be more focus on interventions at lower BLLs. Paradoxically, 
with lower levels it becomes harder to demonstrate differences between populations and to document 
change in BLL as a health outcome of preventive interventions. Future studies may need to utilize 
other health outcomes or non-health outcomes such as changes in environment, knowledge or behavior 
and should collect information on non-housing-based lead exposure sources.  
We did examine other sources of lead exposure, and except for a relatively high percentage of 
parents (39.8%) with work experience in industries with potential lead exposures, our cohort did not 
have non-housing sources of exposure. Our study did document positive changes, such as increased 
parental knowledge and cleaning activity (representing a behavioral change) and decreased home lead 
dust levels, which seemed to result from our interventions.  
Study limitations include lack of detailed knowledge about the comparison group of children, the 
low number of families following through with the process for study-provided lead remediation work, 
and the lower number of families completing all three home visits through study attrition.  
A higher participation rate for remediation work and/or study visits might have resulted in lower 
BLLs for the LSH Study cohort. A recent study looking at aggregate remediation efforts in Chicago Int. J. Environ. Res. Public Health 2012, 9 1223 
 
 
attempted to derive estimates of the effect of remediation, working with census tract level data [17]. 
Since percentage of houses remediated is an indicator of old, poorly-maintained housing, this kind of 
research has to deal with numerous confounders, which can only be partially controlled even with 
individual-level data, let alone census tract-level data. After adjustment for confounding, Jones 
confirmed that remediation appears to lower the prevalence of lead poisoning (defined as an elevated 
BLL of ≥10 μg/dL). He also found that, citywide, 2.5 cases of lead poisoning were adverted for every 
housing unit remediated. Lastly, he found that benefits from decreased prevalence, such as increased 
expected lifetime earnings and decreased medical expenditures for poisoned children, were valued at 
2–20 times the estimated costs of the home remediation [17].  
Despite the recognized benefits of lead remediation observed in the Jones study and by others, the 
practical experience of our LSH study team was that it was apparently difficult for study families to 
commit to receiving such remediation work. The families that remained in the study may represent 
those who were more likely to maintain a cleaner home and take actions to prevent lead exposure. 
Those children that received the blood lead testing around two years of age might have had more proactive 
parents or health care providers (although a blood lead screen is recommended for all two-year-old 
children in Philadelphia), or higher levels around one year prompting parents to request repeat testing.  
Conducting studies in poor urban communities is challenging as many families have competing 
interests, many of them related to obtaining basic life services such as housing, food, employment, 
child care, etc. Therefore, imposing another commitment (such as a study protocol) can be too much 
for some families to absorb into their lives and adhere to. We did not randomize a group to receive no 
intervention, but to two different intervention levels with use of a similar group of children for 
comparison, due to concerns that IRB approval might not be forthcoming for a protocol utilizing a 
group not receiving interventions. Strengths of the study include obtaining a large N for both the 
cohort and comparison groups and a relatively long study intervention period. A relatively large 
number from both groups had blood lead levels available for both the one and two year analysis, 
although these numbers did drop for the two year analysis. 
5. Conclusions 
A comparison of geometric mean blood lead levels and percentages above several BLL cut points 
drawn around age two years in a group of urban newborns benefitting from educational and environmental 
interventions versus a group of similar urban children did not yield statistically significant differences. 
Both groups had relatively lower lead levels when compared to historical cohort groups and this may 
reflect a continuing downward trend in BLLs in U.S. children. Documenting significant changes in 
blood lead levels as a result of interventions may be increasingly difficult due to this trend and other 
outcomes of primary prevention may need to be studied. The study interventions did result in benefits 
to the families such as an increase in parental knowledge about lead exposure/poisoning prevention 
and in-home wet cleaning activity, and a decrease in lead dust levels in study homes.  
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Appendix 
Regression 1: Controlled for age and insurance type 
Coefficients 
a 
Model Unstandardized  Coefficients Standardized  Coefficients  t  p value 
B Std.  Error  Beta 
1 (Constant)  0.825  0.154    5.356  0.000 
Group  −0.032 0.040  −0.042  −0.806 0.421 
Age at 2 year 
BLL 
−0.056 0.055  −0.053  −1.018 0.309 
Insurance  −0.086 0.032  −0.137  −2.732 0.007 
a Dependent Variable: Logarithm (base 10) of BLL at year 2; Key: Group is coded: 1 = LSH, 2 = control; 
Age is in years, with 2 decimals places; Insurance is 1 = Medicaid insurance 2 = private health insurance; 
Regression equation: Log (Y-2 BLL) = −0.042*group -0.053*age −0.137*insurance. All standardized weights. Int. J. Environ. Res. Public Health 2012, 9 1226 
 
 
Regression 2: Controlled for age, insurance type, and year 1 BLL 
Coefficients 
a 
Model Unstandardized 
Coefficients 
Standardized 
Coefficients 
t  p 
value 
B Std.  Error  Beta 
1 (Constant)  0.553  0.148    3.730  0.000 
Group  −0.009 0.037  −0.012  −0.239 0.812 
Age at 2 year 
BLL 
−0.057 0.054  −0.053  −1.062 0.289 
Year 1 BLL  
(log base 10) 
0.420 0.044  0.456  9.459  0.000 
Insurance  −0.051 0.030  −0.081  −1.678 0.094 
a Dependent Variable: Logarithm (Base 10) of year 2 BLL; Key: Group is coded: 1 = LSH,   
2 = control; Age is in years, with 2 decimals places; Insurance is 1 = Medicaid insurance 2 = private health insurance;  
Regression equation: Log (Y-2 BLL) = −0.012*group −0.053*age + 0.456*Y-1 BLL − 0.081*insurance. All 
standardized weights.  
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